Medicine and Dentistry
Adaptive Behavior
5%
Adverse Event
6%
Allergic Encephalitis
53%
Anti N Methyl D Aspartate Receptor Encephalitis
15%
Autoantibodies
8%
Brain Disease
7%
Brain Metabolism
5%
Burnout
10%
Cancer Immunotherapy
5%
Connective Tissue Disease
5%
Demyelination
5%
Diagnosis
13%
Differential Diagnosis
6%
Disease
13%
Emergency Department
5%
Encephalitis
31%
Encephalomyelitis
5%
Epileptic Seizure
11%
Fluorodeoxyglucose
6%
Fluorodeoxyglucose F 18
5%
Immune Checkpoint Inhibitor
16%
Immune-Related Adverse Events
5%
Immunosuppressive Treatment
5%
Infectious Encephalitis
5%
Intensive Care Unit
20%
Ketogenic Diet
7%
Magnetic Resonance Imaging
15%
Malignant Neoplasm
8%
Metastatic Carcinoma
8%
Methylprednisolone
9%
Modified Rankin Scale
7%
Multiple Sclerosis
7%
Neoplasm
5%
Nervous System
6%
Neurologic Disease
20%
Neurological Complication
6%
Neurology
17%
Occipital Lobe
5%
Onset Age
5%
Positron Emission Tomography-Computed Tomography
15%
Quality Improvement
5%
Retrospective Cohort Study
5%
Retrospective Study
6%
Status Epilepticus
13%
Thymoma
5%
Vasculitis
5%
Virus Infection
5%
Voltage-Gated Potassium Channel
5%
Wellbeing
5%
Wernicke Korsakoff Syndrome
5%
Neuroscience
Antibodies
5%
Aspartic Acid
5%
Autoantibodies
11%
Behavior (Neuroscience)
7%
Brain Metabolism
5%
Burnout
5%
Connective Tissue
5%
Creutzfeldt Jakob Disease
5%
Delirium
6%
Dextro Aspartic Acid
7%
Eicosanoid Receptor
11%
Electroencephalography
10%
Electroencephalography
7%
Encephalitis
100%
Fluorine-18
12%
Immunoglobulin G1
5%
Ketogenic Diet
11%
Leucine
5%
Limbic Encephalitis
6%
Magnetic Resonance Imaging
19%
Metabolic Pathway
6%
Methyldienolone
7%
Methylprednisolone
5%
Multiple Sclerosis
12%
Myasthenia gravis
5%
Nervous System
5%
Nervous System Disorder
9%
Neurological Disorder
5%
NMDA Receptor
21%
Occipital Lobe
8%
Positron Emission Tomography
6%
Positron Emission Tomography
5%
Positron Emission Tomography-Computed Tomography
29%
Status Epilepticus
24%
Synapsin I
5%
Visual Pathway
5%
Voltage-Gated Potassium Channel
5%
Keyphrases
18F-FDG PET-CT
11%
18F-fluorodeoxyglucose PET
5%
Adaptive Behavior
5%
Anti-NMDAR Encephalitis
10%
Autoimmune Encephalitis
58%
Brain FDG-PET
6%
CNS Demyelination
5%
Creutzfeldt-Jakob Disease
5%
CT Analysis
5%
Diagnostic Value
5%
Differential Diagnosis
6%
Encephalitis
19%
Epilepsy
5%
Etiology
11%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
6%
Glutamic Acid Decarboxylase 65 (GAD65)
5%
Hypermetabolism
5%
Intensive Care Unit
8%
Leptomeningeal Disease
5%
Leucine
5%
Methylprednisolone
8%
Modified Rankin Scale
8%
Multiple Sclerosis
5%
Nervous System
5%
Neural Autoantibodies
5%
Neurohospitalist
10%
Neurologic
5%
Neurological Examination
7%
Neurological Impairment
7%
Neurological Manifestations
5%
Neurology
10%
Neuroscience
5%
New Diagnosis
5%
New-onset Refractory Status Epilepticus (NORSE)
11%
Occipital Lobe
5%
Paraneoplastic Syndrome
6%
Positron Emission Tomography-computed Tomography (PET-CT)
8%
Quality Improvement Project
5%
Radiation Therapy
5%
Risk Score
10%
Seronegative Autoimmune Encephalitis
7%
Smartphone Use
5%
Staff Perceptions
5%
Survivors
6%
Training Requirements
5%
Urinary Tract Infection
5%
Viral Controllers
5%
Viral Encephalitis
5%
Wernicke-Korsakoff Syndrome
5%
West Nile Virus Infection
5%
